MCS
CLX icon

Metatron Capital SICAV’s Clorox CLX Stock Holding History

Metatron Capital SICAV’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$314K Buy
+1,800
New +$300K 0.3% 99

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Metatron Capital SICAV's CLX Position: Q4 2021 in Review

Metatron Capital SICAV opened a new position in Clorox (CLX) in Q4 2021: 1,800 shares worth $314K. The stake represents 0.3% of the portfolio and ranks #99 among its holdings.

1,219 funds tracked by Wall St. Rank hold CLX as of Q4 2021.

  • Metatron Capital SICAV held 1,800 shares of Clorox worth $314K as of Q4 2021.
  • Clorox was a new Metatron Capital SICAV position in Q4 2021.
  • Clorox made up 0.3% of Metatron Capital SICAV's portfolio in Q4 2021, its #99 holding.
  • 1,219 funds tracked by Wall St. Rank held Clorox as of Q4 2021.

Based on Metatron Capital SICAV's 13F filing for Q4 2021, filed 15 Feb 2022.